News

We have an IND (Investigational New Drug) open, what's next? A new article on the CureFFI blog by Eric Minikel

Author: Hasier Eraña From the laboratory of Sonia Vallabh and Eric Minikel, at the Broad Institute in Boston, come new developments.

Absence of transmission of chronic wasting disease (CWD) prions to human brain organoids

Author: Enric Vidal One of the many questions that remain unanswered in the field of animal prion diseases

Towards early detection: Positive RT-QuICR is associated with slower disease progression

Author: Maitena San Juan Neurodegenerative Creutzfeldt-Jakob disease (CJD) is a prion disorder caused by the misfolded form of Creutzfeldt-Jakob disease (CJD).

Mood disturbances could be an early sign of Creutzfeldt-Jakob disease

Author: Eva Fernández-Muñoz Creutzfeldt-Jakob disease (CJD) is a rare and rapidly progressive neurodegenerative disorder caused by the Creutzfeldt-Jakob virus (CJD).

The Spanish Foundation for Prion Diseases submits its application to the Ministry of Health for the inclusion of prion diseases in the ELA Act.

Author: Joaquín Castilla An essential step in the defence of the rights of patients and their families In a

New strategies to understand and combat sporadic Creutzfeldt-Jakob disease through integration of genetic data

Author: Nuno Anjo Sporadic Creutzfeldt-Jakob disease (sCJD) is a rare, fatal, and rapidly progressive neurodegenerative disease, for which the disease is known as sCJD.

ION717 clinical trial completes patient enrolment

Author: Eric Minikel (translated by Joaquín Castilla) Ionis Pharmaceuticals announced (see original letter) this morning that

Scientists discover early brain alterations in people at risk of developing hereditary Creutzfeldt-Jakob disease

Author: Cristina Sampedro Prion diseases can appear spontaneously or genetically, the latter being caused by a mutation in the prion.

Amyotrophic Lateral Sclerosis joins the group of diseases known as prion-like diseases.

Author: Jorge Moreno Charco Prion diseases, or Transmissible Spongiform Encephalopathies (TSEs) could be defined as a group of diseases

Research priorities on the role of α-synuclein in the pathogenesis of Parkinson's Disease

Authors: Nerea Larrañaga and Paula Marco Scientists at the International Parkinson and Movement Disorders Society (MDS) have published

en_GBEnglish (UK)